Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Sandoz Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
Moxonidine 200 microgram film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Appearance: All tablets are round, approximately 6 mm in diameter. The tablets are light pink. |
Each tablet contains 0.2 mg moxonidine.
Excipient: lactose monohydrate
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Moxonidine |
Moxonidine has been shown to bind selectively to the I1-imidazoline receptors in the brain stem. These imidazoline-sensitive receptors are concentrated in the rostral ventrolateral medulla, an area which is of crucial importance for central control of the peripheral sympathetic nervous system. The result of this effect on the I1-imidazoline receptors has been apparent in reduced activity in the sympathetic nerves. (demonstrated for cardiac, splanchnic and renal sympathetic nerves). |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Film-coating: Hypromellose |
PVC/PVDC/Al blister pack with 10, 20, 28, 30, 50, 60, 98, 100, 400 (20 × 20, 10 × 40, as hospital pack sizes only) film-coated tablets.
Not all pack sizes may be marketed.
Sandoz Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
PL 04416/1287
05th August 2008
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
